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Introduction
Rickettsial infections are known causes of illness and death worldwide. Evidence is 
accumulating that these diseases especially scrub typhus and spotted fever are re-
emerging in India (15, 36-38, 61, 68)
As these diseases present as acute undifferentiated febrile illness, a high index of 
suspicion is essential  in diagnosing this condition. This is further  compounded by 
non-availability of specific tests to diagnose rickettsial infections in most centers. The 
less  sensitive  but  inexpensive,  Weil–Felix  test,  still  remains  the  main  stay  of 
laboratory diagnosis/confirmation of these infections in India. Many clinicians still 
rely on dramatic response to doxycycline therapy for confirming rickettsial disease in 
doubtful cases (15, 37) 
In recent times, we have reported an increased incidence of rickettsial infections in 
children in south India by using this test. (OX-2 & /or OX-19 titer ≥80 is considered 
suggestive) in conjunction with careful correlation of clinical features. Even though 
the sensitivity of Weil-Felix was around 40% , good correlation between the results of 
this test and immunofluorescence assay (IFA) was observed(20). 
In case of acute infections a significant antibody titer is observed at the end of first 
week,  concomitant  with  the  detection  of  IgM antibodies,  whereas  IgG antibodies 
appear  at  the  end  of  second  week  (6,  26).  The  immunofluorescence  assay  for 
detecting  rickettsial  antibodies  adapted  to  a  micro-method  format,  the  micro-
immunofluorescence test (MIF) is the investigation of choice. This test which allows 
the simultaneous detection of IgG and IgM antibodies is available only in reference 
laboratories (49).
ELISA is demonstrated to be as sensitive and specific as MIF for the diagnosis of 
spotted fever (6). Moreover, the ELISA has been found to be more sensitive than the 
MIF  for  the  detection  of  low  levels  of  antibodies  present  in  the  early  stages  of 
infection/disease (7, 27). In addition, the ELISA can be automated and is less prone to 
intra-observer and inter-observer variation. 
Direct detection of rickettsia by inoculation of guinea pigs, eggs or cell culture is 
hazardous and is to be attempted only in a reference laboratory (27). At present, the 
direct diagnostic test that is useful during the acute illness is immunohistolochemical 
examination of cutaneous biopsy of a rash (52). Availability of a highly sensitive and 
versatile  technique for detection of rickettsial  DNA like,  the PCR has provided a 
means of diagnosis even before seroconversion.  The sensitivity of the PCR assay 
depends on the specimen and the technique used.
About 20 rickettsia specific genes have been sequenced to date; of these five genes 
have been proposed for use in the identification of rickettsia including the spotted 
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fever group of rickettsia.  They are the genes encoding the 16S rRNA, the 17kDa 
protein, citrate synthase, OmpA and OmpB (4, 35, 63, 72).
Presently at our centre, we are routinely offering the spotted fever and scrub typhus 
IgM ELISA in addition to the Weil –Felix test for diagnosis. We suspect many cases 
of rickettsial  infection such as spotted fever  and scrub typhus are missed as IgM 
antibodies are detectable by these assays after the first week of infection.
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Aim of the study:
To determine the utility of serological and molecular techniques in the diagnosis of 
spotted fever group of rickettsial infections.
Objectives of the study:
A. To standardize a polymerase chain reaction (PCR) assay for the detection of 
spotted fever group rickettsia.
B. To evaluate the utility of PCR and IgM ELISA in confirming the clinical 
diagnosis of spotted fever.
C. Comparison of whole blood and skin biopsy of the rash (specimen) for 
detection of spotted fever group (SFG) rickettsia by PCR.
       D. Confirmation of PCR amplification by sequencing of three randomly selected 
PCR products of the two gene targets used.
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Review of literature
History:
In 1899, Edward E. Maxey was the first  to describe the clinical  condition named 
Rocky Mountain spotted fever (RMSF), the prototypical tick-borne rickettsiosis. In 
1906, Howard T. Ricketts reported the role of the wood tick in the transmission of the 
causative agent, subsequently named Rickettsia rickettsii. Conor and Bruch in 1909 
differentiated  Mediterranean  spotted  fever  (MSF)  from viral  exanthems.  In 
1919, S. Burt Wolbach proved that ticks were the vectors that maintained Rickettsia  
rickettsii in nature. He also described the histopathology of the lesions of RMSF. For 
almost  a  century,  R.  rickettsii was  the  only  tick-borne  rickettsia  conclusively 
associated with human disease in the Western world. During the 20th century, other 
SFG rickettsiae have been detected in North American ticks. They include Rickettsia  
parkeri in 1939, Rickettsia montanensis (previously named R. montana) in 1963, and 
Rickettsia  rhipicephali in  1978  (46).  However,  these  rickettsiae  are  generally 
considered nonpathogenic to humans (53, 57).
Demonstration of disease transmission by ticks by Ricketts  led to a public health 
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campaign that targeted the elimination of ticks. The observation of small bacillus that 
could  not  be  cultivated  by  Ricketts  revealed  that  bacterial  diseases  could  be 
transmitted from pests to people via vectors. These findings were published in the in 
1909 and the  Rickettsia are named in honor of Howard Ricketts for his pioneering 
work. In 1915, Weil and Felix devised a tube agglutination test named after them(46) 
which is still used in resource poor settings, especially in India for the diagnosis of 
rickettsial infection. 
In India, the clinically entity termed as Indian tick typhus (ITT) was described to be 
prevalent since the beginning of the 20th century but has not yet been isolated from 
cases (46). 
Agents:
Members of the genus Rickettsia including the spotted fever group (SFG) rickettsiae 
are short, rod-shaped, or coccobacillary organisms,  0.8 to 2.0 µm long and 0.3 to 0.5 
µm  in  diameter.  They  are  seen  stained  bright  red  against  a  pale  greenish  blue 
background by Giminez staining (Giminez DF, 1964). Rickettsia were described as a 
group based on filterability,  poor staining with aniline dyes,  gram negativity,  and 
staining  with  Giemsa  or  Castaneda  stains.  Hans  Zinsser  pointed  out  that  some 
rickettsia  like the  trench fever  agent  could be propagated  on cell  free  media and 
appear as red coccobacilli on Giminez staining. They therefore were not obligatory 
intracellular parasites and hence, did not belong in the genus Rickettsia (77) . 
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All over the world rickettsiae are emerging or re-emerging as major pathogens. The spotted 
fevers group (SFG) composes a large group of tick, mite and flea-borne zoonotic infections 
that are caused by closely related rickettsiae.  
Taxonomic status:
The order  Rickettsiales includes the families  Rickettsiaceae and  Anaplasmataceae. 
The most numerous and important genus is  Rickettsia.   Analysis of the 16S rRNA 
(rrs) gene sequences has suggested that Coxiella burnetii, the agent of Q-Fever and 
Bartonella quintana, which causes trench fever are phylogenetically unrelated to the 
alpha1 subgroup of proteobacteria which includes the genus Rickettsii (1, 75). 
Rickettsiae  were  traditionally  divided  into  three  groups  using  phenotypic  criteria. 
They are the typhus group, the spotted fever group, and the scrub typhus group. In 
1995, Tamura et al proposed reclassification of Rickettsia tsutsugamushi the causative 
agent of scrub typhus in to a new genus Orientia tsutsugamushi using 16S rRNA (rrs) 
gene sequence analysis (69). According to Stothard and Fuerst,  Rickettsia bellii  and 
Rickettsia canadensis phylogenetically predate the typhus –spotted fever group split 
and need to be included in to a separate group named the ancestral group. At present, 
the genus Rickettsia contains 25 validated species classified in to four groups.
7
         
Transitional group (flea borne spotted fever) (ref)
              Rickettsia felis
Gillespie et al (2007) have opined that  Rickettsia felis should be included in a new 
group called the transitional group (TRG) based on detailed characterization of the 
conjugative plasmid (pRF) genes. (11) 
 
Epidemiology of Spotted fever:
Only a few tick-borne rickettsioses are present on more than one continent, most are 
confined to a particular area, limited by the presence of their vectors (57). Between 
1984 and 2004, nine species or subspecies of tick-borne spotted fever rickettsiae were 
designated  as  emerging  pathogens  throughout  the  world.  They  are  R.  japonica 
(Japan), “R. conorii caspia” (Astrakhan and Kosovo) R. africae  (sub-Saharan Africa 
and  West  Indies),  R.  honei (Flinders  Island,  Tasmania,  Australia,  Thailand),  R. 
slovaca (Europe),   “R.  sibirica  mongolitimonae” (China  and  Africa),  R. 
heilongjiangensis   (China),  R. aeschlimannii  (Africa and Europe) and R.  parkeri 
(USA) (44).
Rocky Mountain spotted fever (RMSF): 
Rocky Mountain spotted fever is the prototypical and most severe tick-borne spotted 
fever rickettsiosis, and is caused by Rickettsia rickettsii. Mortality as high as 66% has 
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been reported for this illness in the pre-antibiotic era (46). The tick vectors involved 
in transmission are from the Dermacentor  and Amblyomma genera. The infection is 
endemic in the rural areas of the Atlantic seaboard and mid-western USA; here most 
cases occur from April to August (71). In addition infection has been reported from 
Central and South America also (46). Inoculation eschars are rarely seen in Rocky 
Mountain  spotted  fever,  and  a  generalized  exanthema,  typically  purpuric,  maybe 
absent in some 10% of the cases. Some patients with Rocky Mountain spotted fever 
may develop meningitis. The presence of purpuric rash in such patients will lead to 
difficulties in diagnosis as it cannot be distinguished from meningococcemia . About 
500 cases of Rocky mountain spotted fever (RMSF) are reported yearly in the USA, 
predominantly in children below 16 years  of age cases with peak incidence from 
April to August.
In sub-Saharan Africa, seven spotted fever group pathogenic rickettsias are known to 
occur.  They  are  Rickettsia  conorii  conorii,  R.  conorii  caspia,  R.  africae,  R.  
aeschlimannii; R. sibirica mongolitimonae; R. felis and R. massiliae. In addition to 
the  occurrence  of  the  ubiquitous  murine  typhus,  epidemic  typhus  affects  tens  to 
hundreds of thousands of persons who live in Sub-Saharan with civil war, famine and 
poor conditions (40).
African tick bite fever (ATBF):
Rickettsia Africae is responsible for African tick bite fever which is endemic in most 
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of  sub-Saharan  Africa  and the  French West  Indies  (22).  The  vectors  involved in 
transmission are ticks of the  Amblyomma genus, especially  Amblyomma hebraeum 
and  Amblyomma variegatum.   The illness is usually acquired in rural areas where 
wild game or domestic cattle are present. The tick vectors are active throughout the 
year  are  aggressive  and actively attack  humans.  An exposed individual  thus  gets 
multiple tick bites and many members in a given group, maybe attacked at the same 
time. In addition, a prospective cohort study of 940 short-term travellers to rural sub-
equatorial Africa, demonstrated that African tick bite fever occurred at an incidence 
ranging from 4.0–5.3% (18).
Mediterranean spotted fever (MSF):
Mediterranean  spotted  fever,   also  known  as  ‘boutonneuse’  fever,  is  caused  by 
Rickettsia conorii is endemic around the Mediterranean basin, the Middle East, India, 
and in parts of sub-Saharan Africa. It is transmitted by the dog tick,  Rhipicephalus 
sanguineus. In an endemic area like southern France, the incidence is as high as 50 
cases / 100,000 inhabitants, with most cases occurring from May to September (58). 
MSF usually occurs in urban and suburban areas. A single inoculation eschar (in 70% 
of the cases) and a generalized maculopapular rash (in >95% of the cases) are the 
important clinical features in addition to fever (59). 
Indian tick typhus:  The causative agent of Indian tick typhus is  R. conorii  subsp.  
Indica  and  is  transmitted  by the  brown dog tick  Rhipicephalus.  sanguineus.  The 
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disease is endemic in India, where it was described as early as the beginning of the 
20th century (17). The disease resembles Mediterranean spotted fever except that the 
rash  in  Indian  tick  typhus  is  purpuric,  and  an  inoculation  eschar  is  extremely 
uncommon (16). Seven cases among labourers working in tea estates in Kerala have 
been diagnosed by MIF (68).
Astrakhan fever: 
Since 1983, some 1000 cases of Astrakhan fever, caused by R. conorii subsp. caspia 
have been reported in the Caspian basin (70). The name is derived from a region of 
Russia located by the Caspian Sea called as Astrakhan where cases have 
occurred since the 1970s.  Rash is seen in most patients whereas as tache noire 
(eschar) is seen in about a quarter of the cases. The dog tick Rhipicephalus pumilio is 
the  principal  vector  (70).  Astrakhan fever  rickettsia  has  also been  detected  in  R. 
sanguineus ticks collected from dogs and military personnel in Kosovo The clinical 
features are similar to that of Mediterranean spotted fever  but an inoculation eschar 
maybe seen in only 20% of the cases (9).
Queensland tick typhus:
Queensland  tick  typhus  caused  by  Rickettsia  australis occurs  in  rural  eastern 
Australia.   It  is  transmitted by ticks of the Ixodes genus and 60 cases have been 
reported since 1946 (64).
About two thirds of the patients exhibit an inoculation eschar and, like African tick 
bite  fever,  the  cutaneous  rash  is  most  often  vesicular  rather  than  maculopapular. 
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Fatalities are rare (17).
North Asian tick typhus (Siberian tick typhus): 
Rickettsia sibirica causes North Asian tick typhus (Siberian tick typhus). This disease 
is endemic in large parts of rural northern Asia, including the former USSR, China 
and Mongolia with sero-positivity rates exceeding 60% in some endemic areas. Most 
cases occur between May and September (31).
Rickettsial pox: 
Rickettsial pox caused by Rickettsia akari is the only known mite-borne spotted fever 
group  rickettsiosis.  It  is  transmitted  by  the  bite  of  bloodsucking  infected  mites 
(Allodermanyssus  sanguineus) and characterized by a  primary eschar,  fever  and a 
papulo-vesicular rash. Culture confirmed cases have been reported from  the USA, 
Ukraine and Croatia and in 1997 from South Africa (21). 
Japanese spotted fever (JSF): 
Three rickettsial  diseases  are  known to  exist  in  Japan currently:  Japanese  spotted 
fever caused by R. japonica (JSF), scrub typhus, and Q fever.  JSF occurs along the 
coast of central and southwestern Japan, whereas TD and Q fever occur all over the 
country. From 1984 to 2004, 484 cases of JSF have been reported from Japan. In 
contrast, 300-1000 cases of scrub typhus occur every year (33). Preliminary data from 
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tick  surveys  suggests  that  Haemophysalis  flava and  Haemophysalis  hystericis as 
vectors of JSF. Two other serotypes or species of spotted fever group rickettsiae have 
been isolated from ticks in Japan; one is closely related to R. helvetica and the other 
whose genotype is unknown, is closely related to a Slovakian genotype (33). In a 
study undertaken in the Western Province of Sri Lanka,  31 patients with possible 
rickettsioses were identified.  Scrub typhus was diagnosed in 19 and spotted fever in 
eight (50).
Though  Rickettsia  aeschlimannii was  first  isolated  from ticks  in  1997  only  two 
human  cases  have  been  reported  world-wide  till  2004  (17).  R.  sibirica  subsp. 
mongolotimonae and R. heilongjiangensis cause disease in China, Mongolia, Siberia, 
Armenia and Pakistan (76).
Flea-borne  spotted  fever:  Flea-borne  spotted  fever  is  caused  by  R.  felis and  is 
transmitted by the cat flea, Ctenophalides felis. Human infection has been described 
since 1994 from USA, Mexico,  Brazil,  Germany,  Spain,  Tunisia,  Thailand,  South 
Korea and Laos (48). 
 Data from India:
Padbidri  et  al  (1984)  stated  that  Indian  tick  typhus  exists  as  a  zoonosis  after  an 
extensive  study on  tick-borne  rickettsioses  in  Pune,  Maharashtra.  Of  the  11  tick 
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species examined,  R. conori was found in  Boophilus microplus and  Rhipicephalus  
haemaphysalis. Antibodies against the R. conori antigen were detected in the sera of 
Rattus blanfordi, R.r. rufescens and Suncus murinus by complement fixation test (41). 
More recently, Kamarasu et al (2007) have opined that scrub typhus and rickettsial 
illness are distributed in Tamil Nadu based on a serological study conducted over two 
years (2004 & 2005). In 2004, 115 of 306 samples and in 89 of 964 samples tested 
demonstrated positive titers for scrub typhus by the Weil-Felix test. Positive titers for 
other rickettsial illness were observed in 44 samples (19). There is ample evidence 
from our centre that the number of cases of scrub typhus  and spotted fever tends to 
increase during the cooler months (Prakash JAJ, unpublished).  
A study undertaken at  our  centre  by Somashekar  et  al, from November  2003 to 
November  2004,  screened  180  children  with  an  acute  febrile  illness.  Typhus  or 
spotted fever was diagnosed in 43 children. Seventy percent of the cases occurred 
during the cooler months (i.e.  June –December).  Of these, 27 (62.8 per cent) had 
scrub typhus, 14 (32.6 per cent) had spotted fever and 2 (4.7 per cent) had infection 
with  R.  typhi.  A  mortality  rate  of  4.7  per  cent  was  observed  as  two  children 
succumbed to their illness (66). Moreover, spotted fever cases have been reported 
from Kerala  Karnataka, Assam and most recently from Himachal Pradesh, were two 
cases confirmed by microimmunofluorescence assay have been reported (32).
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Pathogenesis:
Till  date  20 rickettsial  genomes have  been fully sequenced.  Totally 17 rickettsial 
surface cell  antigen (sca)  genes numbered 1 to 17 have been described (39). The 
rOmpA and rOmpB(sca5) are high molecular weight proteins encoded by surface cell 
antigen gene (sca) and help in the attachment of bacteria to the host cells (30). The 
sca4 gene is known as gene D, it encodes for a phospholipase D. Phosholipase D has 
been postulated to be responsible for the cytotoxic effect on host cells infected by 
rickettsia  (60)  and  for  survival  of  rickettsiae  in  arthropods.  Phosholipase  A2  is 
responsible for mediating host cell entry and allows the spotted fever rickettsia to 
escape phagocytosis by lysis of the phagosomal membrane(74). Immune responses 
are induced by rOmpA, rOmpB and sca4 (geneD) (60).
The preliminary event  in  rickettsial  infection  is  entry of  organisms  into  the  skin, 
through  the  bite  of  the  arthropod  vector.  Rickettsiae  have  a  predilection  for 
endothelial cells and hence infect all organs having a vasculature (74).  They attach to 
host cells with the help of adhesions OmpA and OmpB (46). Once attached, they 
induce  the  host  cell  to  phagocytose  by  receptor  mediated  endocytosis  (74). 
Phosholipase A2 enables the SFG rickettsiae to escape from the host cell phagosome 
and promoting  intracellular  proliferation.  Rick  A causes  actin  polymerization  and 
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allows the cell to cell spread of bacteria leading to a disseminated infection without 
host cell lysis (12). Infection of the endothelial cells leads to increased permeability 
of the microvasculature and is due to the disruption of the adherens junctions between 
these cells (74).
Pathology: 
Histopathologic examination reveals features of septic vasculitis. In the early lesions 
the  infiltrates  consist  of  a  perivascular  lymphohistiocytic  infiltrate  along  with 
extravasated  red  blood cells  and  oedema of  the  dermis.   This  progresses  later  to 
leukocytoclastic  vasculitis.  Basal  cell  vacuolization,  lymphocytic  exocytosis  fibrin 
thrombi and capillary wall necrosis is also seen infrequently (25). 
Clinical features: 
In  tick  borne  rickettsioses  symptoms  appear  6  to  10  days  after  the  tick  bite. 
Characteristically an inoculation eschar is seen at the site of the tick bite in addition to 
fever, headache, muscle pain rash and local lymphadenopathy (2). The rash in spotted 
fever is macular and blanching, becomes erythematous, maculopapular with petechial 
hemorrhages in fully evolved cases (25). Purpura fulminans is seen in severe cases. 
The rash typically begins on the extremities and then spreads centripetally and often 
involves the palms and soles .
Treatment: 
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As soon as infection is suspected samples are taken for confirmation of diagnosis and 
specific therapy is to be instituted without delay for best results. The drug of choice is 
doxycycline even for young children (25). Chloramphenicol is a useful alternative 
especially  in  those  allergic  to  doxycycline.  Other  drugs  used  are  josamycin  for 
pregnant women (3 g per day for 7 days).  Chloramphenicol also can be used for 
pregnant women except near term. 
Laboratory diagnosis of spotted fever: 
Isolation of spotted fever group (SFG) rickettsiae: 
The ultimate method for diagnosis and also discovery of a new species is isolation of 
the  organism  in  culture.  As  all  rickettsiae  including  spotted  fever  group  (SFG) 
rickettsia are obligate intracellular parasites cultivation will be successful only when 
attempted in media containing cells or by inoculation into susceptible animals (27). 
The ability to cultivate rickettsia provides a constant source of antigens which can be 
used for  serological  assays.  Culture  needs  to  be undertaken in  Biosafety level  III 
containment facilities and requires extensively trained personnel. In addition, the best 
results  are  obtained when the  sample is  inoculated  immediately on receipt  in  the 
laboratory and when treatment has been delayed till sample is collected. 
Samples such as buffy coat of heparinized blood, defibrinated whole blood, triturated 
clot, plasma, skin biopsy, and arthropod samples (including hemolymph) have been 
used (2). 
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Inoculation of animals and embryonated eggs:  In the past guinea pigs and mice 
have been used for isolation and also for eliminating mycoplasma from contaminated 
cell cultures . Yolk sac inoculation of embryonated chicken eggs has also been used 
previously for isolation of rickettsia. These methods have been replaced now by the 
more efficient and comparatively less cumbersome cell culture methods including the 
shell vial culture techniques (34).
Cell  culture:  Various  adherent  cell  lines  have  been  used  successfully  to  isolate 
rickettsia in biosafety containment level III facilities. The cell lines commonly used 
are  Vero  (African  green  monkey  kidney),  L929  (mouse  fibroblast),  HEL (human 
embryonic lung fibroblasts), XTC2 (Xenopus laevis, tick cell line) and MRC5 (human 
lung fibroblast) (27, 51)
As the sensitivity is low and also time taken for detection is longer, conventional cell 
culture has been replaced by shell vial culture in the reference centers undertaking 
rickettsial isolation by culture.  
Shell  vial  culture  technique: This  technique  which  was  originally  described  for 
cytomegalovirus  isolation  has  been  adapted  by  Marrero  and  Raoult  (1989)  for 
isolation of R. conorii using HEL fibroblasts (34). In 1991, Kelly et al, demonstrated 
that isolation of rickettsiae is  better  and occurs  earlier  when  Vero  or  L929  shell  vial 
cultures are used (23). The crucial step that determines the sensitivity of this method is that shell vial 
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should  be  centrifuged  after  the  material  has  been  inoculated.  The  reason  for  this  being  that 
centrifugation enhances rickettsial attachment and cell penetration (2, 23). In spite of the increased 
sensitivity  of  this  technique,  about  a  third  of  rickettsiae,  have  been  shown  to  be  nonviable  on 
subsequent  passage  (46).   Confirmation  is  by  microscopic  examination  after  Acridine  orange  or 
Gimenez or immunofluorescence staining or PCR (2).
The time taken for growth is usually 48 -72 hours) (27). La Scola and Raoult have 
reported that in 34 (43%) of the 79 samples from untreated patients, R conorii was 
isolated by shell  vial  culture  technique.  They also reported that  the  sensitivity of 
isolation increases to 50% when CECs are used (13).
Immunohistochemistry: Spotted fever group rickettsia can be detected in tissues by 
using  immunohistochemcal  methods.  Immunofluorescence  technique  and 
immunoperoxidase methods have been used to detect rickettsia in tissue specimens 
both fresh or formalin treated and paraffin embedded. Though the specificity is 100%, 
sensitivity ranges from 53 % and 75% (55, 73) are superior to stains such as Giemsa 
or Giminez . False-negative results have been attributed to therapy with tetracycline 
or chloramphenicol more than 24 hours prior to sampling and inability to uobtain a 
tissue sample from the focus  of  vasculitis  (73).   Immunohistochemical  assays  for 
antigen detection provide better resolution of cells around the detected rickettsiae and 
can be performed on archived specimens (42) 
Serology
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The most frequently used methods for diagnosis are serological assays. The major 
problem encountered in serological  diagnosis  is  the occurrence of  cross-reactions. 
Cross reactivity is due to the similarity of antigens of pathogens within the same 
genus and sometimes from different genera (54). 
Weil-Felix test: 
Weil-Felix test  is  still  the only assay available in  many diagnostic  laboratories in 
India. This assay has been replaced by more sensitive assays such as MIF (micro-
immunofluorescence assay) and ELISA for detection of IgM and IgG antibodies. The 
Weil-Felix test  uses  Proteus antigens as these have antigens which share epitopes 
with rickettsial antigens with the exception of  R. akari  (54) The  Proteus vulgaris 
OX-2 antigen reacts with sera from persons infected with SFG rickettsiae. The  P. 
vulgaris  OX-19 antigen reacts with sera from individuals suffering form typhus and 
spotted  fever  (RMSF) .  As this  assay detects  predominantly IgM antibodies  it  is 
negative in Brill-Zinsser disease, were an IgG response is observed. The advantages 
of this  test  is  that  a single  sample can be processed,  can be performed as a tube 
agglutination or a micro-plate agglutination and antigens can be easily produced in-
house (minimal risk) especially in resource poor situations . 
 Complement Fixation Test (CFT): 
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The complement  fixation (CF) test  has been used in the past  for the detection of 
antibodies  specific  for  rickettsiae.  Though  purified  rickettsial  antigens  which  are 
species specific have been used, cross-reacting antibodies among the SFG and typhus 
groups  have  been  observed  (65).  In  addition  to  requiring  culture  facilities  and 
expertise for production of these antigens, results depend on how the antigen was 
produced and how much was used.
Micro-immunofluorescence assay: 
Micro-immunofluorescence assay uses the micro-method format to detect rickettsial 
antibodies.  This  test  is  an  adaptation  of  the  immunoflourescence  assay  and  is 
considered  the  serologic  reference  test  for  diagnosis  of  rickettsioses  (49).  The 
significant titer for detection of IgG and IgM antibodies to Rickettsia conorii (MSF) 
is ≥ 128 & ≥64.  For infections caused by other spotted fever rickettsia, the cutoff 
titers are ≥ 64 for IgG and/or ≥32 for IgM antibodies (2).
The  diagnostic  titer  will  vary  from  region  to  region  and  is  dependent  on  the 
endemicity of the infection in the population being studied. For RMSF, a sensitivity 
ranging from 84.6% to 100% and a specificity of 99.8 to 100% has been reported  (2). 
A sensitivity of 46% to 100% has been documented for MSF by MIF (2).  MIF assays 
using the whole selection of antigens are available only in reference centers.  
ELISA: 
ELISA has been found as sensitive and specific as MIF of RMSF by Clements and 
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co-workers in 1983 (6). In addition, ELISA detects the low levels of antibodies seen 
during  late  convalescence.  Keysary  and  Strenger  have  concluded  that  lipo-
polysacharide (LPS) ELISA is able to differentiate between MSF and murine typhus 
in  patients  whose  sera  show cross  reactions  by MIF (24).  ELISA needs  minimal 
equipment and expertise. Hence it can serve as a useful diagnostic tool in centers 
which lack the infrastructure necessary to provide a MIF assay or culture or PCR for 
diagnosis of rickettsial infections. 
We use a commercially available IgM ELISA for spotted fever which uses Rickettsia  
rickettsii as the antigen. The manufacture (PanBio Ltd, Brisbane, Australia) states that 
cross  reactions  can  occur  with  the  typhus  group  rickettsiae.  A  sensitivity  and 
specificity  of  98.2% and 93.6% has  been  demonstrated  by using  the  MIF as  the 
reference test. 
Other serological tests:
(IHA) and Latex agglutination test:  These assays are passive agglutination tests 
which  are  able  to  detect  both  IgG  and  IgM  antibodies  to  spotted  fever  group 
rickettsia.  Both use erythrocyte  sensitizing substances (ESS) as antigen.  The latex 
agglutination is more sensitive than the IHA. The reason for this is attributed to the 
fact that the antigenic fractions on the latex beads are more in number than those on 
the erythrocytes (14).
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Western  blot  (WB) assay after  cross-absorption  (CA)  has  been  used  in  reference 
centers to help to determine the rickettsial agent responsible for illness by antibody 
evaluation (27).A study done by Raoult et al (2001) demonstrated that 81 of the 414 
subjects evaluated were positive by MIF with CA and WB (56). A specificity and 
positive predictive value of 100% was seen with both techniques (56). 
According to Parola et al (2005) a rickettsia is said to be the agent responsible for 
infection if the IgG or IgM antibody titer against this rickettsia is  at least two or more 
serial dilutions greater than IgG or IgM antibody titers against other rickettsia. When 
the  above  criteria  is  not  satisfied,  Western  blot  assays  with  or  without  cross-
absorption needs to be performed (47).
It is also important to remind clinicians that collection of acute and convalescent-
phase serum specimens, separated by several weeks, is necessary to confirm disease. 
Polymerase chain reaction
Samples suitable for PCR amplification of rickettsial DNA are skin biopsy specimens 
including biopsy of eschar, peripheral blood mononuclear cells, whole blood, blood 
clot and serum (2). Nested PCR is sensitive by two orders of magnitude than standard 
PCR in the detection of the required target, making it a better test for detection of 
DNA  from clinical  specimens  (29).  Targets  that  have  been  used  for  PCR-based 
detection are the 17-kDa protein encoding gene (genus common antigen gene, htrA), 
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citrate synthase gene (gltA),  ompA, ompB  and geneD (encodes for phosholipase D) 
and  these  have  been  used  successfully  by  many  researchers  for  detection  and 
characterization of rickettsia (46) .
Fournier et al have devised a nested PCR known as suicide PCR in which single use 
primers which were never used in the laboratory previously were used. Skin biopsy 
specimens  from  103  individuals  diagnosed  to  have  rickettsioses  were  studied. 
Culture, standard PCR and suicide PCR was performed on all. Of these 32 (31.0%) 
were  culture  positive,  47  (45.6%)  were  positive  by  standard  PCR.  Skin  biopsy 
specimens of 70 (68.0%) of the 103 patients were positive by “suicide PCR”(10).
Yeon-Joo Choi et-al evaluated a nested PCR detect rickettsial DNA using gltA and 
rOmpB gene primers in 200 serum samples from febrile individuals in South Korea. 
Rickettsial DNA was detected in 24 individuals. Rickettsia conorii, R. japonica, and 
R.  felis  and R.  typhi were  the  rickettsia  identified  by  sequence  analysis  of  the 
amplicons (3). 
A nested PCR to detect a 267 bp amplicon of the rOmpB gene of SFG rickettsiae was 
designed and evaluated by the same group using primers derived from the R.conorii 
strain Seven. As low as seven copies per assay, were detected by this nested PCR. 
SFG rickettsial DNA was found in 71 of the 100 MIF positive serum samples tested 
(5).
Leitner et al (2002) developed a nested PCR for detection of TG and SFG rickettsia 
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by amplifying a 214-bp DNA fragment of the R conorii 17-kDa protein genes (29). 
Restriction fragment length polymorphism (RFLP) was used to differentiate between 
these two groups of rickettsiae. The assay was shown to have a detection limit of 10 
copies per assay. They were able to detect the requisite target in all the five serum 
samples and six of the seven tissue samples from the MSF cases that succumbed to 
their illness (29).
Tzianabos et  al  (1989)  suggested  that  it  is  possible  to  detect  spotted fever  group 
rickettsial DNA from blood clots by amplifying a 246 bp fragment of 17-kDa antigen 
gene by PCR. Of the nine culture positive RMSF patients, only seven were positive 
by PCR.   The  standard  PCR described  by Tzianabos  et  al  can  detect  100  fg  of 
rickettsial DNA which is equivalent to detection of 60 rickettsiae (72).
Massung  etal  (2001),  designed  a  nested  protocol  for  amplifying  the  same  gene 
(17kDa) for detection of DNA from the typhus group rickettsiae.  Using this protocol 
typhus  group  rickettsial  DNA  was  amplified  from  the  CSF  of  a  patient  with 
meningitis  from New Mexico.  A  combination  of  the  above  mentioned  two  PCR 
protocols  has  been  recommended  by  Parola  et  al  (2005)  for  detection  of  SFG 
rickettsial DNA from blood, serum, skin biopsy and tick specimens (46). Moreover, 
they have opined that for routine identification of rickettsia, detection of the  OmpA 
and gltA genes by PCR will suffice (46).
Real time PCR: 
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Stenos  et  al  (2005)  designed a  qPCR assay that  detected a  74bp fragment  of the 
citrate synthase gene (gltA) of rickettsia belonging to the spotted fever and typhus 
group. The assay was found to detect one target copy number per reaction. Therefore, 
the authors feel that this assay would be very useful for the diagnosis of rickettsial 
illnesses, when rickettsial numbers are very low (67).
Eremeeva  et  al  (2003)  described  a  SYBR  Green  assay  which  detects  a  154bp 
fragment of the rOmpA gene of spotted fever rickettsia. The detection limit of this 
assay was found to be 5 copies per reaction. The qPCR was found to be as sensitive 
as the plaque assay and was useful  in the quantitation of rickettsia  from infected 
tissues (8).
Paris et al (2008) designed a multiplex qPCR for detection of scrub typhus group, 
typhus group and spotted fever group of rickettsiae using the 47kDa, gltA and OmpB 
genes as targets.  The amplicon sizes were 74 bp for  gltA,  118 bp for  47 kDa and 
252 bp for ompB genes. Detection limits were 24 copies/µl, 5 copies/ µl & 1 copy/µl 
respectively. Melt-curve analysis was used to detect group specific amplicons. The 
assay was subjected to 54 samples, of which all cell-culture and 75% of characterized 
clinical buffy coat samples were correctly identified (43).
A novel real-time multiplex PCR assay using Taqman probes has been designed and 
found to have good analytical sensitivity and specificity (Prakash JAJ, unpublished). 
This assay is able to detect as low as 2 copies of plasmid DNA of the three targets 
specific for scrub typhus (56 kDa gene), typhus group (17-kDa gene) and the spotted 
fever group rickettsiae (ompA gene) respectively. 
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Though there has been serological evidence for the presence of spotted fever in Tamil 
Nadu, molecular tests have not been evaluated for diagnosis of the same. This study 
was taken up with objective of assessing the usefulness of molecular techniques in the 
diagnosis of spotted fever.
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Materials and methods
Subjects: 
Children above the age of 6 months and adults with fever (≥5 and ≤15 days) and rash 
were enrolled  into the  study,  if  found eligible  as  per  the  inclusion  and exclusion 
criteria  enumerated  below.  These  subjects  were  included  after  evaluation  by  a 
dermatologist and after ruling out drug reactions and viral exanthems, by history and 
examination (A clinical proforma was also filled up as given in Appendix II at the 
time  of  sample  collection.  Informed  consent  was  obtained  from  all  individuals 
recruited: Appendix I).
Inclusion criteria: 
1.  Age ≥ 6 months
2.  Fever ≥5 and ≤15 days 
3.  Rash:  non  confluent  maculopapular  rash  with  or  without  purpura/purpura 
fulminans.
Exclusion criteria:
1.  Age ≤ 6 months
2.  Individuals with duration of fever less than 5 days or more than 15 days 
3.  No rash
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Samples: 
Skin biopsy from the rash, whole blood and serum utilized for the study. A 3×3mm 
sized  piece  of  skin  was  taken  by  punch  biopsy  as  per  standard  protocol  after 
administration of local anesthesia to the site.  Whole blood (5ml) was collected in 
EDTA tube (Vacuette, Greiner Bio-one GmbH, Kremsmunster, Austria) and clotted 
blood in a serum collection tube (BD Vacutainer, BD, Franklin Lakes, NJ, USA) for 
serology.
Study period:  November 2006 to April 2008
Tests  done  on  the  samples  collected  from  patients  recruited  into  the  study 
Serum: Spotted fever IgM ELISA, scrub typhus IgM ELISA and Weil-Felix test
Whole blood: Nested PCR for detection of citrate synthase gene (gltA) and  17kDa 
gene of rickettsia.
Skin biopsy:   Nested PCR for detection of citrate synthase gene (gltA) and 17kDa 
gene of rickettsia.
All the above mentioned tests were evaluated for the diagnosis of spotted fever 
using the case definition given below.
Case definition of spotted fever used in this study:
Individual with fever (≥5 and ≤15 days) and non confluent maculopapular rash with 
or without purpura / purpura fulminans in whom defervescence of fever was observed 
within 48 hours of initiating doxycycline therapy with no detectable IgM antibodies 
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to scrub typhus by ELISA.  
Statistical analysis:
Sample size: In this study the clinical inclusion criteria used is specific for spotted 
fever.  About 30% laboratory confirmation has been described in literature, in a less 
clinically defined group. As the present study used more rigid clinical criteria, the 
reasonable expectation of prevalence was considered as 40-50%. Therefore, sample 
size was calculated with an expected prevalence of 50%, desired precision of 15% 
and 95% confidence interval. Using these criteria the minimal number of samples to 
be tested was determined as 43.  (Epi Info 6 version 6.04b to c).
 
Test sensitivity, specificity, negative predictive value, and positive predictive value 
were calculated by using a 2 X 2 table using the case definition described above. The 
Kappa co-efficient (for assessing the agreement of serological and molecular tests) 
was calculated using (Epi Info 6 version 6.04b to c) 
Serology
Serum was separated by centrifugation at 2500g for 10mts. IgM ELISA for spotted 
fever rickettsiae and scrub typhus was performed using a commercial kit (PanBio Ltd, 
Brisbane,  Australia)  as  per  manufacturer’s  instructions.  The  test  was  considered 
positive when the serum sample tested showed a value of ≥16 Units. Antigens used 
for the scrub typhus and spotted fever ELISA are the recombinant 56kDa protein and 
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the Rickettsia rickettsii antigen.
The Weil-Felix test was done with in-house antigens prepared and interpreted as per 
the protocol followed currently in the department. A titer of ≥80 with OX 19 and / or 
OX 2 was considered positive for rickettsial infection and OX K ≥80 was taken as 
scrub typhus positive.
PCR:
Whole blood and skin biopsy specimens (3mm X 3mm, punch biopsy) of each of 
these patients stored at -70° C before DNA extraction.
DNA extraction from whole blood: 
DNA was extracted from frozen whole blood using Flexi Gene DNA kit  (Qiagen 
GmbH, Hilden, Germany) as per procedure described by the manufacturer.  Prior to 
extraction  the  whole  blood  sample  was  subjected  to  a  pre-purification  procedure 
using a lysis buffer (containing 20mM Tris, 10 mM EDTA and pH 8). The Flexigene 
protocol subsequently followed for extraction is as described below:
1. Buffer  FG 1  (25ml/sample)  was  transferred  into  a  50  ml  centrifuge  tube. 
Whole blood (5-6 ml) was added and mixed by inverting the tube five times.
2. The mixture was centrifuged for 5 min at 2000g.
3. The supernatant was discarded and the tube was inverted on a clean piece of 
absorbent paper for 2 min, taking care that the pellet remained in the tube.
4. Buffer FG2/QIAGEN Protease (prepared earlier) was added and the closed 
tube was immediately vortexed until the pellet was completely homogenized. 
31
5. Once homogenization was complete, the tube was inverted three times and 
placed in a heating block and incubated at 65º C for 10 min.
6. Isopropanol (5 ml) was added and mixed thoroughly by inversion until the 
DNA precipitate became visible as threads or a clump.
7. The mixture was centrifuged for 3 min at 2000xg.
8. The  supernatant  was  discarded  and  the  tube  inverted  on  a  clean  piece  of 
absorbent paper for 2 min, taking care that the pellet remained in the tube.
9. Five  ml  of  70% ethanol  was  now added  and  the  mixture  vortexed  for  5 
seconds and centrifuged for 3 min at 2000xg 
10. The supernatant was discarded and the tube was inverted on a clean piece of 
absorbent paper for 5 min, taking care that the pellet remained in the tube
11.  The DNA pellet obtained was air dried until all the liquid evaporated).
12.   One ml of Buffer  FG3 was added to the dried pellet  and the same was 
vortexed for 5 seconds at low speed, the DNA was completely dissolved by 
incubating for one hour at 65º C in a heating block.
 The extracted DNA was stored as 10 µl aliquots at -70° C pending testing by PCR.
DNA Extraction from skin biopsy:  
DNA was extracted using QIAamp Blood DNA Mini Kit (Qiagen GmbH, Hilden, 
Germany)  for  DNA purification  from tissue  as  per  manufacturer’s  instruction  as 
follows.
1. The skin biopsy specimen was placed in a 1.5 ml micro centrifuge tube and 
180 µl of ATL Buffer  was added. 
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2. To  this  mixture,  20  µl  Proteinase  K  was  added  and  mixed  by  vortexing 
followed by incubation at 56ºC until the tissue was completely lysed.
3. The sample was pulse vortexed for 15 seconds after adding 200 µl of Buffer 
AL, followed by incubation at 70ºC for 10 min. 
4. Absolute alcohol (200 µl) was added to the sample and mixing done by pulse 
vortexing for 15 seconds. 
5. The resulting mixture from step 4 was carefully applied to the to the QIAamp 
spin column. Centrifugation was done at 6000xg (8000rpm) for 60 seconds 
and the tube containing the filtrate was discarded.
6. The spin column was placed into a new clean two ml collection tube and 500 
µl buffer AW1 was added.  The column was centrifuged at 6000xg (8000rpm) 
for 60 seconds, the tube containing the filtrate was discarded. The spin column 
was placed in a new, clean 2 ml collection tube. 
7.  Five hundred micro-liters (500 µl) of buffer AW2 was added into the spin 
column  and  centrifuged  at  20000xg  (14000rpm)  for  3  minutes.  The  tube 
containing the filtrate was discarded.
8.  The spin column was placed in a clean 1.5 ml microcentrifuge tube and 200 
µl  buffer  AE  was  added.  After  incubation  at  room  temperature  for  five 
minutes, the column was centrifuged at 6000xg (8000 rpm) for one minute. 
The extracted DNA was eluted by this procedure and stored as 10µl aliquots 
at -70° C pending further testing by PCR.
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iii)  PCR amplification: 
Citrate  synthase  gene  (specific  for  all  rickettsiae)  (4,  63)  and  the  17kDa antigen 
(specific for spotted fever rickettsiae) (35, 72) are amplified by nested protocol. The 
thermal  cycler  used  was  the  ‘Veriti’  96  well  Fast  Thermal  Cycler  (Applied 
Biosystems, Foster City, CA, USA).  Primers were synthesized by Sigma-Genosys, 
Bangalore,  India.  Genomic  DNA  from  Rickettsia  parkeri,  kindly  provided  by 
Professor JS Dumler, Division of Medical Microbiology, Department of Pathology, 
Johns Hopkins Medical Institutions, Baltimore, MD, USA was used as the positive 
control.    
Standardization of the PCR assays used:
Standardization was done using annealing temperature starting from 45°C to 56°C° 
and MgCl2  concentrations starting from 2 mM to 12 mM  with an increasing interval 
of 2 mMol /reaction. Subsequently the optimal temperature and duration for extension 
was determined. The optimal conditions obtained for each are given below for both 
the primary & secondary reactions for the two targets detected.  
a) Detection of Citrate Synthase Gene (4)
Primary reaction (first round)
A 380 -bp fragment of the citrate synthase gene (gltA) gene was amplified by using 
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primers already described (4, 63).The sequence of the primers used is as given below:
RpCS. 877p (forward): 5’ - GGG GAC CTG CTC ACG GCG G – 3’
RpCS. 1258n (reverse): 5’ - ATT GCA AAA AGT ACA GTG AAC C –3’
 PCR Mix: 
A  8  µl  portion  of  extracted  DNA  was  amplified  in  a  100  µl  reaction  mixture 
containing 10 pmol of each primer, 200 µM each of dATP, dCTP, dGTP, dTTP, 1.25 
Units of Taq DNA polymerase (Applied Biosystems, Foster City, CA, USA), 5 mM 
MgCl2 and 10 x PCR buffer without MgCl2  and PCR grade water (MilliQ, Millipore 
Corporation, Bedford, MA, USA) to make up the volume to 100 µl.
Amplification parameters: 
PCR amplification included an initial denaturation of 95°C for 2 minutes followed by 
35 cycles of denaturation at 95°C for 30 seconds, annealing at 50°C for 20 seconds, 
extension at 68°C for 25 seconds and concluded with a final extension at 72°C for 3 
minutes. 
Secondary reaction
 A 338 fragment of the citrate synthase gene was amplified using the primers whose 
sequences are given below (4).
RpCS.896p (forward): 5’ - GGC TAA TGA AGC AGT GAT AA– 3’
RpCS. 1,233n (reverse): 5’ - GCG ACG GTA TAC CCA TAG C– 3’
PCR mix:
A 1 µl portion of the primary amplicon was amplified in a 50 µl reaction mixture 
containing 10 pmol of each primer, 200 µM each of dATP, dCTP, dGTP, dTTP, 1.25 
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Units of Taq DNA polymerase (Applied Biosystems, Foster City, CA, USA), 3 mM 
MgCl2 and 10 x PCR buffer without MgCl2  and PCR grade water (MilliQ, Millipore 
Corporation, Bedford, MA, USA) to make up the volume to 50 µl.
Amplification parameters: 
PCR amplification included an initial denaturation of 95°C for 2 minutes followed by 
35 cycles of denaturation at 95°C for 30 seconds, annealing at 52°C for 30 seconds, 
extension at 68°C for 30 seconds and concluded with a final extension at 72°C for 3 
minutes.
b) Detection of 17kDa antigen encoding gene: (35, 72). A 246 bp fragment of the 
coding region of the 17-kDa antigen gene amplified by using nested protocol
Primary reaction
The primers R17122 and R17500 sequences described (35) are as given below
R17122 (forward): 5’ - -CAGAGTGCTATGAACAAACAAGG– 3’
R17500 (reverse): 5’ - CTTGCCATTGCCCATCAGGTTG– 3’
PCR Mix:
A 8 µl  portion of  extracted DNA will  be amplified in a  100 µl  reaction mixture 
containing 10 pmol of each primer, 200 µmol each of dATP, dCTP, dGTP, dTTP, 
1.25 Units of Taq DNA polymerase (Applied Biosystems, Foster City, CA, USA), 5 
µM  MgCl2  and  10  x  PCR  buffer  without  MgCl2  and  PCR  grade  water  (MilliQ, 
Millipore Corporation, Bedford, MA, USA) to make up the volume to 100 µl.
PCR amplification:
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Amplification consisted of initial denaturation at 94°C for 3minutes, followed by of 
40 cycles comprising, denaturation at 94 for 30 seconds, annealing at 52°C  for 30 
seconds,  extension at 67°C  for 30 seconds and final extension at 72°C for 3 minutes.
Secondary reaction
The primers Tz15 and Tz16 described by Tzianabos et al in 1989 (72) were used and 
the sequences are as given below
Tz 15 (forward) 5’-TTC TCA ATT CGG TAA GGG C-3’
Tz 16 (reverse) 5’-ATA TTG ACC AGT GCT ATT TC-3’
PCR Mix: 
A 1µl portion of amplicon is taken as template and amplified in a 50 µl reaction
mixture containing 10 pmol of each primer, 200 µM each of dATP,  dCTP  dGTP, 
dTTP, 1.25 Units of Taq  DNA polymerase (Amplitaq, Applied Biosystems, Foster 
City, CA, USA)), 2 µmol MgCl2 and 10 x PCR  buffer without MgCl2 and PCR grade 
water  (MilliQ, Millipore Corporation, Bedford, MA, USA) to make up the volume to 
50 µl.
Amplification parameters:
Amplification consist of 35 cycles, each cycle comprising of initial denaturation at 
94°C  for  3min,  denaturation  at  94  for  30  sec.  Annealing  at   52°C  for  30  sec, 
Extension at 72°C for 30 sec, final extension at 72°C for 3 min.
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Detection of PCR product:
The citrate synthase gene PCR amplified product [10 µl] and the 17kDa protein gene 
product (10 µl) was electrophoresed in a submarine electrophoresis unit in a 1.5% 
agarose gel  stained with ethidium bromide.  The amplified product  was visualized 
using a gel documentation system (Bio-Rad Laboratories, Hercules, CA, USA).
Sequencing
Randomly selected three PCR amplified products (three each for the 17-kDa Antigen 
gene and the citrate synthase gene) were subjected to a sequencing reaction. The Big 
Dye terminator cycle sequencing Kit (Applied Biosystems, Foster City, CA, USA) 
was used for the sequencing PCR as per the protocol described by the manufacturer. 
The ABI 310 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA) was 
used to enumerate the sequence. The sequence obtained was analysed by using the 
basic  local  alignment  search  tool  (BLAST,  available  from 
www.ncbi.nlm.nih.gov/BLAST) program  with  the  available  standard  reference 
sequences in the Gene Bank for homology. The Megablast format of this program 
which searches for highly similar sequences was used for analyzing the sequences.
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Results
From  November  2006  to  April  2008,  59  individuals  with  fever  and  rash  were 
recruited  into  this  study.  Of  these,  32  were  males  (54.2%) and 27  were  females 
(45.8%).  A diagnosis of spotted fever was made in an individual who had fever of 
five  to  fifteen  day  duration  with  rash,  in  whom defervescence  of  fever  occurred 
within  48  hours  of  doxycycline  therapy with  negative  serology for  scrub  typhus. 
Using this case definition, 42 of the 59 subjects enrolled were diagnosed as spotted 
fever. Among these 42 cases, 22 (52.4%) were males and 20 (47.6%) were females. 
Figs 1-3 show the different types of rash encountered in our patients. 
Fig. 1. Patient with spotted fever having an erythematous, maculopapular non-
confluent rash
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Fig. 2. A spotted fever case with purpuric rash. Note the erythematous papule 
with central purpuric area. 
Fig. 3. Purpura fulminans (healing) seen in a child with spotted fever. 
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Fig. 4.  PCR for citrate synthase gene (gltA).  Gel picture showing the 338 bp 
gene product amplified by nested PCR of skin biopsy specimens. 
Positive samples: 3, 4, 9 and 17 
Positive controls: sample 7 and 18  
Negative control: 16
Fig. 5.  PCR for 17-kDa gene. Amplified  246 bp  partial gene product in gel 
analysis. 
PC  is  positive  control  (Rickettsia  parkeri),  NC  is  negative  control.  Positive 
samples: 38, 41, 45 and 19. 
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The age distribution of patients with fever and rash including those who have been 
diagnosed as spotted fever is as given in fig.6.
Fig. 6.  Age wise distribution of patients with fever and rash 
Note: Children aged 6 years and less constituted more than half of the positive cases, 
i.e. 25 of 42 (59.5%).
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Fig. 7. Geographical location of study subjects and spotted fever cases
The maximum numbers of cases were from Chittoor district in Andhra Pradesh. Of 
the 27 cases of fever with rash recruited into the study from this area, 23 (85%) were 
diagnosed as spotted fever as per the case definition used. 
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Fig. 8. The geographical distribution of the patients depicted in the histogram (fig. 7)
The mean duration of fever among study subjects was 9.8 ± 3.4 days; among those 
with spotted fever  was 10.5 ± 3.4 days  and in  those who were not  diagnosed as 
spotted fever was 8.2 ± 3.3 days. 
Among  the  42  spotted  fever  cases,  IgM  ELISA  for  spotted  fever  detected  37 
(88.10%) cases.  PCR done on skin biopsy and whole blood specimens for citrate 
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synthetase gene (gltA) and 17-kDa gene detected 38 (90.48%) and 23 (54.76%) cases 
respectively. Among the17 patients who were not spotted fever, ELISA has given two 
false positives and skin biopsy  gltA PCR has given one false positive result.  It  is 
interesting to note that the skin biopsy PCR for 17-kDa gene did not show any false 
positives but failed to detect 15 (39.47%) of the 38 spotted fever cases detected by 
skin biopsy gltA PCR.  Both PCRs failed to detect four (9.52%) spotted fever cases 
whereas ELISA was unable to detect five (11.90%) of 42 diagnosed as spotted fever 
according to the case definition. 
         
In addition to the IgM ELISA for scrub typhus and spotted fever, the Weil-Felix test 
was also performed on the serum samples. The Weil-Felix test was positive in 14 
(33.33%) of the spotted fever cases. Though the sensitivity of the Weil-Felix test is 
low, it did not show any false positive results.
As the gltA PCR is more sensitive than the 17-kDa gene PCR performed on skin 
biopsy specimens in this study, it has been compared with the ELISA and the data is 
shown in Table 1. The agreement between tests was compared by determining the 
Kappa coefficient using [Epi-info 6, (version 6.04 b to c)]
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Table 1: Comparison of citrate synthase gene PCR with IgM ELISA in the
                diagnosis of spotted fever
Clinical Spotted fever
Negative Positive
gltA PCR and ELISA POS 0 34
gltA PCR and ELISA NEG 14 1
gltA PCR POS, ELISA NEG 1 4
gltA PCR NEG, ELISA POS 2 3
      
Observed agreement between tests:              88%    
Kappa coefficient:                                       0.72 (>0.40 significant)
Z value                :                                        5.37 (>1.96 significant)
P value                :                                        <0.0005 
             
Table 2 shows the performance of the IgM ELISA in the diagnosis of spotted fever. 
Of the 39 spotted fever IgM ELISA positives, 37 were diagnosed as spotted fever 
using the case definition. In 34 of these patients,  gltA PCR was positive (33 skin 
biopsy  and  one  whole  blood).  In  three  spotted  fever  cases  where  serology  was 
positive, skin biopsies and whole blood gltA PCR could not detect rickettsial DNA. 
The skin biopsy gltA PCR detected four spotted fever cases that were negative by 
serology for spotted fever by IgM ELISA. 
Among the  15 individuals  who were  spotted  fever  IgM ELISA negative  and not 
diagnosed as spotted fever, one patient had a positive result by skin biopsy gltA PCR. 
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This patient also exhibited IgM antibodies to scrub typhus by ELISA (patient had 
eschar)  and subsequently expired in spite of treatment with doxycycline.  The two 
spotted fever IgM ELISA false positives were negative by gltA PCR and 17-kDa PCR 
done on skin biopsy and blood and also by the Weil Felix test. However, these two 
samples were positive for IgM antibodies to scrub typhus by ELISA and showed the 
expected clinical response to doxycycline. 
Table 2: Evaluation of ELISA in the diagnosis of spotted fever
Clinical Spotted fever
Positive Negative TOTAL
ELISA  POS 37 2 39
ELISA  NEG 5 15 20
TOTAL 42 17 59
(A value of ≥16 PanBio units was considered as positive)
Sensitivity of ELISA                :                88.10%
Specificity of ELISA                :                88.24%
Positive predictive value         :                 94.87%
Negative predictive value       :                 75.00 %
Table 3 demonstrates the ability of the citrate synthase gene PCR in the diagnosis of 
spotted fever.  The aforementioned PCR assay detected 38 (36 skin biopsy + two 
whole blood) of the 42 cases of spotted fever. In four of these cases  gltA PCR was 
negative (both skin biopsy and whole blood) but in three of these cases IgM ELISA 
for spotted fever was positive. One spotted fever case was negative by both the PCR 
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assays  (done  on  both samples),  spotted  fever  IgM ELISA and scrub typhus  IgM 
ELISA with therapeutic response to doxycycline. In the spotted fever negative group, 
the  lone  false  positive  result  by  gltA PCR  (skin  biopsy  positive,  whole  blood 
negative) was also negative by spotted fever IgM ELISA, 17-kDa gene PCR (both 
skin biopsy and whole blood). This patient was positive by scrub typhus IgM ELISA 
and succumbed despite treatment with doxycycline.  
Table 3: Evaluation of PCR for detection of rickettsial citrate synthase (gltA) 
gene in the diagnosis of spotted fever
Clinical Spotted fever
Positive Negative TOTAL
PCR  POS 38 1 39
PCR  NEG 4 16 20
42 17 59
Sensitivity of PCR                  :                90.48%
Specificity of PCR                  :                94.12%
Positive predictive value        :                97.44%
Negative predictive value       :                80.00%
The above table shows that gltA PCR detected the desired target in 39 (37 skin biopsy 
and 2 whole blood) of the 59 patients recruited into the study.  Of the 37 skin biopsy 
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gltA PCR positives,  one sample  was  considered  as  a  false  positive  result.  Whole 
blood PCR for  gltA gene picked up 13 cases of which two were skin biopsy PCR 
negative for  gltA.  The 17-kDa gene PCR done using DNA from skin biopsy and 
whole blood was negative in these two patients (Both these two patients were spotted 
fever IgM ELISA positive). In 11 spotted fever cases, DNA extracted from both skin 
biopsy and whole blood was positive by gltA PCR 
All the 23 skin biopsy samples from cases of spotted fever, positive by 17-kDa gene 
were also positive by gltA PCR. All the four whole blood 17-kDa gene PCR positives 
were positive by skin biopsy 17-kDa gene PCR and gltA PCR (skin biopsy and whole 
blood) and diagnosed as spotted fever as per the case definition used in this study.
The gltA gene gave the best yield among the two gene targets used for PCR detection 
of rickettsial  DNA (i.e.  gltA and 17-kDa gene) from both skin biopsy and whole 
blood. Totally 38 patients diagnosed as spotted fever patients were PCR positive by 
gltA gene PCR (skin biopsy = 36, whole blood = 2). Of these 38 spotted fever cases, 
PCR for 17kDa gene picked up 23 (60.52%) positives when DNA from skin biopsy 
was the source. Whole blood 17-kDa gene PCR could detect only four patients with 
spotted fever.  Table 4 enumerates the perfomance of the two PCR assays when done 
on the two samples used in this study
 Table  4:  Comparison  between  samples  and  PCR  gene  targets  used  in  the 
diagnosis of spotted fever (n=39)
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Table 5: Evaluation of Weil-Felix test in the diagnosis of spotted fever (n = 59)
Clinical Spotted fever
Positive Negative TOTAL
Weil-Felix pos. 14 0 14
Weil-Felix neg. 28 17 45
42 17 59
Significant titer for spotted fever by Weil-Felix test: OX19 and /or OX2 ≥80
Sensitivity                                            :                33.33%
Specificity                                            :                100.0%
Positive predictive value                     :                100.0%
Negative predictive value                   :                37.77%
As given in the above table (Table 5) the Weil-Felix test detected only 14 of the 42 
cases of spotted fever. All these cases were positive by gltA PCR and spotted fever 
IgM ELISA. Though the Weil-Felix test showed a low sensitivity in the diagnosis of 
spotted fever it had shown no false positive result in the current study.
50
Fig. 9.  Diagnosis of spotted fever: Sensitivity of tests used and the duration of 
fever.
The relation between fever duration at the time of presentation and the ability of PCR 
and  ELISA  in  diagnosing  spotted  fever  from  the  5th to  15th day  of  illness  is 
enumerated above (fig. 9). On the 5th day of illness, sensitivity of ELISA is 33% and 
that of PCR is 66%.  Eighth day onwards the sensitivity of ELISA is 100% and PCR 
sensitivity varies from 50% to 100%.
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Table 6.  Details of cases showing false positive results by PCR and ELISA
Legend:
* Response- Defervescence of fever within 48 hrs of doxycycline therapy
** Eschar seen on right fore arm
*** Purpura fulminans noted in this patient
Patient  A:  Skin  biopsy gltA PCR false  positive  as  the  fever  did  not  respond to 
doxycycline (scrub typhus IgM ELISA is positive and eschar present on the right fore 
arm). This patient had a fatal outcome.
Patient B &C: Both these patients were considered false positive for spotted fever by 
IgM  ELISA,  were  positive  by  scrub  typhus  IgM  ELISA.   Moreover,  the  fever 
responded to doxycycline in these two patients. It is interesting to note that the values 
obtained in the scrub typhus IgM ELISA are higher than those obtained by the IgM 
ELISA for spotted fever. This gives rise to a suggestion that these two cases are scrub 
typhus and the false positive spotted fever result is due to serological cross reaction.
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Fig. 10. Sequence electrophorogram of citrate synthase (gltA) gene amplified from 
patient no.18.
The forward sequence of the gltA gene obtained by sequencing is depicted above 
(fig. 10). This sequence showed a homology of 98% similarity (with 99% coverage) 
for  Rickettsia  mongolitimonae (DQ097081),  Rickettsia  marmionii (AY737684), 
Rickettsia  sibirica (U59734),  Rickettsia  africae (U59733)  and  Rickettsia  honei  
(U59726) by BLAST analysis (Megablast) which belong to the spotted fever group 
(SFG) rickettsia. 
Similarly, the 17-kDa gene sequence showed 99 % homology (with 100% coverage) 
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for Rickettsia japonica (AB359457), Rickettsia honei strain (AF060704),  Rickettsia  
parkeri (EF689732), Rickettsia conorii str. Malish 7 (AE008675), Rickettsia rickettsii 
(AY281069),  Rickettsia peacockii (AF260571) and  Rickettsia sibirica (AF445384) 
when analyzed by BLAST (Megablast). 
Totally three amplicons each of the gltA and 17-kDa gene target were sequenced. The 
sequenced amplicons differed by three base pairs for  gltA and one base pair for the 
17-kDa gene target when compared with sequences which  were found highly similar 
(≥ 98%) by BLAST analysis (Megablast).  
Discussion:
 There are several non-viral illnesses that present with a fever and rash, which are 
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amenable to antimicrobial treatment; spotted fever is one such clinical condition that 
is  emerging  in  India.  Other  rickettsial  infections  such  as  typhus  fever  and  scrub 
typhus also need to be considered in a cases presenting with fever and rash. Vasculitis 
is the basic pathology in all the aforementioned infections as the agents preferentially 
infect  endothelial  cells  (74).  In  many centers in  India,  the Weil-Felix  test,  whose 
sensitivity is  low,  is  the  only sero-diagnostic  test  available  .  Earlier  reports  have 
documented  the  endemicity  of  rickettsioses  among  children  and  adults  in  the 
Himalayan belt,  Maharashtra,  TamilNadu,  Karnataka and Kerala.  Previous  studies 
done from this centre have clearly demonstrated the occurrence of spotted fever and 
scrub  typhus  as  major  causes  of  preventable  morbidity  and  mortality.  Moreover 
occurrence of a novel spotted fever rickettsia has been demonstrated using serological 
and molecular techniques (61).
Conventional bacteriological media are not useful in isolation of these bacteria as 
they are obligate intracellular  parasites.  Cultivation of rickettsia,  including spotted 
fever group rickettsia (SFGR) is therefore possible only in viable eukaryotic host cells 
only.  The  spotted  fever  group  rickettsia  has  been  isolated  in  the  laboratory  by 
inoculation into animals such as guinea pigs, embryonated eggs and eukaryotic cell 
lines. Primary isolation of clinically important spotted fever group rickettsia is to be 
done in BSL III facilities as it is hazardous. Moreover isolation is technically difficult 
with  limited  use  in  diagnosis.  Nevertheless,  isolation  of  the  organism  is  still 
considered as the diagnostic tool of choice for confirming the etiology of rickettsial 
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illness  (2)  and  for  the  reasons  mentioned  above  is  available  only  in  reference 
laboratories. 
Currently, the most widely used system for primary isolation in reference laboratories 
is  cell  culture  especially  the  centrifugation  shell  vial  technique  using  human 
embryonic lung (HEL) fibroblasts . Culture has to be kept for at least three weeks and 
confirmation of culture has to be done by immunoflourescence staining or by PCR. 
Hence, though it is the most definitive test, it is time consuming and labour intensive. 
Culture techniques are used in reference laboratories to provide a source of antigens 
for  serological  tests  and  for  raising  antisera  for  antigen  detection  by 
immunohistochemistry.
Antigen detection using immunohistochemical methods on formalin-fixed, paraffin-
embedded  tissue  specimens  obtained  at  autopsy  or  cutaneous  biopsy  samples 
(particularly eschars) is confirmatory.  The major drawback of this test is it suffers 
from lack of sensitivity though it  is 100% specific for diagnosis  of spotted fever. 
Under the best circumstances immunohistochemistry shows a sensitivity of 70% (55, 
73). As this test requires the availability of specific antisera (which currently is not 
available commercially), it  is performed only in reference laboratories which have 
facilities for raising these antisera. 
As the traditional identification methods used in bacteriology cannot be applied to 
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rickettsiae,  serological tests are the mainstay of diagnosis  of these infections.  The 
insensitive Weil-Felix test, based on the detection of antibodies to various heterophile 
Proteus antigens that cross-react with rickettsiae, is still  used in many developing 
countries like India for sero-diagnosis of rickettsial infections.  The test of choice of 
for diagnosis of spotted fever is an IFA adapted to a micromethod format. This has 
been termed the micro-immunofluorescence test (MIF) (49)  and allows the detection 
of IgM and IgG antibodies or both. The sensitivity of this test varies from 26 % to 
100% depending on the time of sampling and the agent being studied (2). The full 
panel of antigens to perform these assays and detect the etiological agent is currently 
available  only  at  reference  laboratories  for  reasons  already  cited.  Nowadays, 
rickettsial antibodies can also be detected by the ELISA method, which is considered 
as good as the IFA for diagnosis of spotted fever.
The major limitation of serology is the occurrence of cross-reactions because of intra-
generic  antigenic  similarity  and  occasionally  across  different  genera.  In  addition, 
acute  and  convalescent-phase  serum  specimens,  separated  by  several  weeks,  are 
necessary to confirm disease. Cross-absorption (CA) techniques and Western blotting 
(WB)  are  used  in  reference  centers  to  distinguish  the  rickettsiae  responsible  for 
infection by antibody evaluation (54) 
Parola et al (2005) have stated that “A rickettsial antigen is considered to represent 
the agent of infection when titers of IgG or IgM antibody against this antigen are at 
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least  two serial  dilutions  higher  than titers  of  IgG or  IgM antibody against  other 
rickettsial  antigens.  When differences in titers  between several  antigens are lower 
than  2  dilutions,  Western  blot  assays  and,  if  needed,  cross-absorption  studies  are 
performed” (45). 
Rickettsiae,  including  spotted  fever  group rickettsiae  have  been  detected  by PCR 
amplification from samples such as blood, skin biopsy samples, and arthropod tissues 
(2). As none of the PCR assays to date are specific for individual rickettsial species, 
amplified products are further analyzed by methods like RFLP (62) and or sequencing 
to identify the species detected. An advantage of sequencing the PCR amplification 
product is it enables us to obtain a precise identification of a new isolate. Sequencing 
part  of the genes  coding for,  citrate  synthase (gltA),  a  17-kDa protein,  ompA and 
ompB has been used to characterize and identify new species of spotted fever group 
of rickettsia (4, 35, 63, 72). 
Various studies done (38, 61, 66, 68) in our centre have reported that spotted fever is 
prevalent in south India and needs to be considered among the differential diagnosis 
in patients presenting with fever and rash. This prospective study was undertaken to 
evaluate  the  usefulness  of  molecular  and serological  methods in  the  diagnosis  of 
spotted fever.
A total of 59 individuals with fever and rash were recruited based on the inclusion 
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and exclusion criteria.  Using the case definition a  diagnosis  of  spotted fever  was 
made in 42 of the 59 subjects studied. The case definition used was based on duration 
of fever, presence of rash, response to doxycycline and negative serology for scrub 
typhus.  Almost 60% (25 of 42 cases) of the cases were children aged 6 years and 
below. 
Nested PCR assays to detect the citrate synthase gene (gltA) and the 17-kDa antigen 
gene targets have been evaluated previously for the diagnosis of spotted fever (4, 35).
 These two PCR assays were performed on two specimens, namely whole blood and 
skin biopsy from each subject recruited into this study. The IgM ELISA for scrub 
typhus and spotted fever, the Weil Felix test was performed on all the serum samples 
form patients  recruited  into  the  study and  interpreted  as  per  the  current  protocol 
followed in our laboratory. 
The 338 bp amplification product of  gltA target (for SFG and TG rickettsiae) was 
generated  by nested  PCR in  38  of  the  42  spotted  fever  cases  when PCR results 
obtained for skin biopsy and whole blood DNA were combined. The sensitivity and 
specificity of  gltA PCR is 90.48% and 94.18% respectively when PCR results from 
both samples are combined.  DNA extracted from whole blood was positive by gltA 
PCR in 13 cases. In 11 of these cases skin biopsy also gave the desired result. On the 
two skin biopsy gltA PCR negative samples experiments to rule out inhibitors could 
not be carried as all the DNA was used up. Sample mix up is ruled out as the original 
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container was checked for the same. For one of these patients, the skin biopsy sent for 
histopathological examination was inadequate. In four cases both the skin biopsy and 
whole  blood  was  positive  by  17-kDa  PCR.  An  additional  19  skin  biopsies  were 
positive  for  spotted  fever  group  rickettsial  DNA  by  17-kDa  PCR.  In  one  case 
diagnosed as spotted fever (as per the case definition) serology and molecular tests 
for spotted fever were negative. This patient presented on the fifth day of illness and 
defervescence  of  fever  was  observed within 28 hours  of  initiating treatment  with 
doxycycline. Scrub typhus IgM antibodies could not be detected by ELISA in this 
individual. According to our case definition this is a case of spotted fever which is 
false  negative  by the  serological  and  molecular  assays  used  in  the  current  study. 
Other  rickettsial  illness  such  as  typhus  fever  and  Ehrlichiosis  where  a  similar 
response  to  specific  therapy  is  seen  are  also  possible  diagnosis.  Sequencing 
performed on three skin biopsy amplicons each for the  gltA gene and 17-kDa gene 
followed by BLAST analysis provided confirmatory evidence for specificity of target 
amplification.  The  three  amplicons  sequenced  (of  each  target)  showed  the  same 
sequence but differed by three base pairs (gltA)  and one base pair from the nearest 
match/best  match,  when  compared  with  existing/published  sequences  in  the 
GenBank. This suggests that probably one strain or species (which could be novel) of 
spotted fever group rickettsiae is circulating in our area. This assumption based on the 
available data needs to be assessed further by using other targets such as ompA and 
ompB genes. 
As  the  gltA PCR  used  in  this  study  is  able  to  detect  SFG  and  TG  rickettsiae, 
60
sequencing of these amplicons will be able to prove whether the amplified sequence 
belongs to a SFG and TG rickettsiae.  The sequence analysis of the three gltA gene 
amplicons  gave  unequivocal  evidence  that  only  spotted  fever  rickettsiae  were 
amplified in at least the sequenced samples. The two blood gltA PCR true positives 
and the lone false positive need to be sequenced to confirm amplification by nested 
PCR. Sequence analysis of all amplicons will enable us to direct enquiries for specific 
detection of novel rickettsial genotypes circulating in the community.   
   
In this prospective study, the IgM ELISA and nested PCR for detection of the gltA 
gene have shown comparable sensitivity and specificity in the diagnosis of spotted 
fever. Our data suggests that whole blood for detection of rickettsial DNA by nested 
PCR is not as suitable as skin biopsy specimens. As we used a pre-purification step 
and a standard kit to obtain high quality DNA from whole blood, presence of PCR 
inhibitors is ruled out.  Fournier et al (2004) noted a similar finding and advocated the 
use of suicide PCR to improve sensitivity(10). Tzianabos et al (1989) have opined 
that the amount of circulating rickettsiae may be below the threshold of detection. As 
the detection limit of the gltA and the 17-kDa gene PCR is seven and sixty rickettsial 
copies per reaction respectively, this may be the reason for the decreased sensitivity 
observed with whole blood.
An  increase  in  number  of  cases  of  spotted  fever  was  noticed  during  the  cooler 
months. This  increase in  incidence has  been previously reported for scrub typhus 
from our centre (37). The increase in incidence could be due to increased tick activity. 
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Latha et al in 2004 have opined that rainfall seemed to be the most important climatic 
factor affecting seasonal variation in tick activity (28). As this region receives most of 
its  rainfall  during  the  cooler  months,  surveys  evaluating  tick  activity and disease 
incidence need to be undertaken to confirm this.  
Furthermore, studies using the micro-immunofluorescence test (MIF) and the highly 
sensitive and specific quantitative real-time PCR assay (Prakash JAJ, unpublished) 
are needed. These studies will help in understanding the vector- host relationship in 
this  endemic  area.  A study using the real-time multiplex PCR assay will  also  be 
helpful in arriving at a decision regarding the utility of whole blood in the diagnosis 
of spotted fever.  Lastly, rapid and specific confirmation of the etiology will help in 
directing specific therapy of spotted fever, which will limit morbidity if not mortality. 
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Summary and conclusion
A prospective  study was  under  taken  to  evaluate  the  efficacy of  serological  and 
molecular technique in the diagnosis of spotted fever in 59 clinically suspected cases 
in South-India.
1. A nested  PCR to detect  gltA gene and 17-kDa gene of  spotted fever  group 
rickettsia was standardized. 
2. Using the case definition,  42 cases were diagnosed as spotted fever.  ELISA 
detected 37 cases where as 38 cases were positive by gltA PCR, of these two 
were detected only in blood. The 17-kDa antigen gene was detected in 23 of the 
38 gltA PCR positive cases.
3.  The  gltA PCR  and  ELISA  showed  a  sensitivity  of  90.48%  and  88.1% 
respectively.  A  specificity  of  94.28%,  88.24% was  observed  for  these  two 
assays. 
4. Two false positive results by ELISA and one by skin biopsy gltA PCR were 
observed.
5. Sequencing of three amplified products for each of the targets confirmed PCR 
amplification of spotted fever DNA.  
6. In  the early phase of  illness  (5th day to  8th day)  PCR has  performed better, 
whereas ELISA gives 100% sensitivity from the 8th day onwards.
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7. Whole blood PCR detection rates were low when compared with skin biopsy 
results by PCR. The better performance of skin biopsy is most likely due to the 
presence of larger amount of organisms in endothelial cells of the small blood 
vessels  in  comparison  to  those  found  in  the  peripheral  circulation.  Further 
studies using more sensitive and sophisticated molecular assays such as the real-
time quantitative PCR are needed to prove this.
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APPENDIX-1
INFORMATION & CONSENT FORM
INFORMATION
COMPARISON OF PCR WITH SEROLOGICAL METHODS FOR THE 
EARLY DIAGNOSIS OF SPOTTED FEVER- A PILOT STUDY
Name of Principal Investigator                     Dr.Sohanlal
Research Institution                                     Christian Medical College,  
Vellore-4
Telephone Number                                        0416-2282588
         We request you to take part in this study so that we can evaluate the PCR 
for the early diagnosis of spotted fever in this area.
         We hope this information will improve the management of rickettsial 
diseases. You can choose not to join the study, or you can leave from the study at 
any time, without effect on your medical care.
         If you join the study, you will be requested to provide a sample of blood, 
2-3 mm sized skin biopsy for testing Rickettsia bacteria by PCR. Skin biopsy as 
a specimen for rickettsial diseases is a gold standard test and a well documented 
one. We are evaluating blood as a specimen by a concentrating method and also 
by serology. The result will be provided to your doctor and this may help him / 
her in deciding the management for you. The tests will be done free of cost to 
you. We will also collect clinical data regarding this disease.
          The information obtained in the study will be kept confidential and will be 
accessed only for analysis and reporting the results of the study. No individual 
will be identified in this report.
          If you want any further information about the study you can contact doctor 
who is treating you or at the telephone number given at the top of this form.
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CONSENT
I  understand  the  facts  explained  in  the  information  sheet.  I  agree  to 
participate in this research study.
-------------------------                        -------------------------------------- 
---------------
Name of the participant/guardian     Signature                                             Date
--------------------------                      --------------------------------------- 
---------------
Name of the investigator                   Signature                                            Date
----------------------------                    --------------------------------------- 
---------------
Name of the witness                         Signature                                              Date
APPENDIX-1I
                                                      PROFORMA
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